1. Home
  2. OTH vs ICCC Comparison

OTH vs ICCC Comparison

Compare OTH & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OTH

Off The Hook YS Inc.

N/A

Current Price

$2.62

Market Cap

67.2M

Sector

Industrials

ML Signal

N/A

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$6.08

Market Cap

55.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OTH
ICCC
Founded
2012
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.2M
55.5M
IPO Year
2025
1987

Fundamental Metrics

Financial Performance
Metric
OTH
ICCC
Price
$2.62
$6.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
67.1K
21.4K
Earning Date
12-15-2025
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
0.26
Revenue
$112,361,879.00
$27,769,304.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$624.88
$24.17
Revenue Growth
22.35
16.49
52 Week Low
$1.95
$4.28
52 Week High
$3.90
$7.60

Technical Indicators

Market Signals
Indicator
OTH
ICCC
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
OTH
ICCC

About OTH Off The Hook YS Inc.

Off The Hook YS Inc operates as a nationwide leader in the yacht and boat dealership industry, offering a comprehensive suite of services that spans the entire boat value chain. The company operates as two segments: Boat Sales and Azure Funding. Boat Sales includes Specializing in the buying, selling, and wholesaling of yachts and boats, having a boat dealership created to run Yellow Fin sales in Miami; and Azure Funding includes a recreational loan broker and lender providing financing solutions for individuals, dealerships, and brokerages.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: